ORIENTBIO Inc. (002630) — Cash Flow Quality Index
ORIENTBIO Inc. (002630) has a Cash Flow Quality Index of 0.12x as of March 2024. Operating cash flow of ₩1.35 Billion is below net income of ₩10.99 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore cash efficiency ratio of ORIENTBIO Inc. to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
ORIENTBIO Inc. Cash Flow Quality Index (2007–2024)
Historical Cash Flow Quality Index for ORIENTBIO Inc. across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check cash flow reinvestment rate of ORIENTBIO Inc. to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for ORIENTBIO Inc. (2007–2024)
Year-by-year earnings quality comparison for ORIENTBIO Inc.. For live market cap and the full company financial profile, see market value of ORIENTBIO Inc..
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.29x | ₩3.76 Billion | ₩12.87 Billion | ▲ +324.5% |
| 2022 | 0.07x | ₩2.35 Billion | ₩34.20 Billion | ▼ -98.8% |
| 2013 | 5.80x | ₩5.09 Billion | ₩878.82 Million | ▲ +656.8% |
| 2011 | 0.77x | ₩3.11 Billion | ₩4.07 Billion | ▼ -73.4% |
| 2007 | 2.88x | ₩1.52 Billion | ₩526.73 Million | — |